TCT: New Trial Data on DAPT Duration Following 2nd Generation Stents
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
-
Feres F, Costa RA, Abizaid A, et al, for the OPTIMIZE Trial Investigators. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents. The OPTIMIZE randomized trial. JAMA. 2013; published online October 31, 2013.
-
Scirica BM, Bonaca MP, Braunwald E, et al, for the TRA 2°P-TIMI 50 Steering Committee Investigators. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI Investigators. Lancet. 2012;38:1317-1324.
-
Bhatt DL, Foxx KAA, Hacke W, et al, for the CHARISMA Investigators. Clopidogrel plus aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706-1717.
Disclosure statements are available on the authors' profiles: